Last update Oct. 23, 2024
Compatible
We do not have alternatives for Meglumine Antimoniate since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Meglumine Antimoniate in other languages or writings:
Meglumine Antimoniate belongs to this group or family:
Main tradenames from several countries containing Meglumine Antimoniate in its composition:
Variable | Value | Unit |
---|---|---|
Oral Bioavail. | baja / poor | % |
Molecular weight | 366 | daltons |
T½ | inicial: 2; terminal: 33 - 76 | hours |
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2015 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Pentavalent antimony compounds, such as sodium stibogluconate or meglumine antimoniate, are used as first-line treatment for most forms of leishmaniasis: Intramuscular, intravenous or intralesional administration.
The few pharmacokinetic data known do not allow predicting its possible excretion in breast milk.
Its low oral bioavailability makes it difficult to pass into infant plasma from ingested breast milk, except in premature infants and the immediate neonatal period where there may be greater intestinal permeability.
Authorized for use in pediatrics, even in small infants.
A 4-year-old breastfed girl had severe perioral and oral lesions due to maternal nipple-areola lesions at 3 months of age. She was successfully treated with sodium stibogluconate and meglumine antimoniate. (Costa 1988)
List of essential medicines WHO: compatible with breastfeeding (WHO-UNICEF 2002). American Academy of Pediatrics: antimony compounds are a medication that is generally compatible with breastfeedin. (AAP 2001)